FOXO4-DRI Research for Cellular Senescence
An evidence-based overview of research examining FOXO4-DRI in the context of cellular senescence. This page synthesizes findings from peer-reviewed literature.
Research Summary
FOXO4-DRI was specifically designed to clear senescent cells by disrupting the FOXO4-p53 survival interaction. Preclinical studies show selective elimination of senescent cells with reduction in senescence markers (p16, p21, SA-beta-gal). No human studies have been conducted.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. FOXO4-DRI has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.